2 ballot items.
Two Nasdaq compliance proposals: (1) approval to permit issuance of up to 2,477,292 shares upon exercise of registered Common Warrants issued in Feb 2026 Offering in excess of Nasdaq 19.99% cap; (2) approval to reprice Prior Warrants to $0.6055 and permit issuance of up to 3,020,410 shares upon exercise as amended.
Seek stockholder approval under Nasdaq Listing Rule 5635(d) to permit issuance of up to 2,477,292 shares upon exercise of Common Warrants issued in the February 17, 2026 follow-on public offering (Units), which may otherwise be limited by the Nasdaq 19.99% Exchange Cap.
The proposal asks shareholders to approve, under Nasdaq Listing Rule 5635(d), the issuance of up to 2,477,292 shares of common stock upon exercise of Common Warrants issued in connection with the Company’s February 2026 follow-on public offering. Management seeks this approval because Nasdaq’s 20%/19.99% Exchange Cap prevents issuance of shares upon exercise if doing so would exceed 19.99% of outstanding shares immediately prior to the SPA; without approval the Company could only issue up to 1,646,056 shares under the cap. Approval enables the full potential exercise mechanics contemplated in the SPA, allowing the Company to receive additional capital and meet investor expectations tied to the Offering, but will dilute existing stockholders’ economic and voting interests. The Board recommends a FOR vote, arguing the approval is necessary to comply with Nasdaq rules and to allow the company to issue shares in accordance with the SPA and facilitate potential future funding; the company notes risks including significant dilution, downward pressure on share price if exercisable warrants are converted and potential effects on Nasdaq compliance and liquidity. The proposal is transactional and regulatory in nature, rather than governance or compensation-related, and the board’s rationale centers on operational and listing compliance needs; shareholders should weigh the immediate capital and listing benefits against dilution and market pressure risks.
Seek stockholder approval under Nasdaq Listing Rule 5635(d) to reprice Prior Warrants issued November 20, 2025 to reduce exercise price from $2.41 to $0.6055 (the public offering Unit price) and approve issuance of up to 3,020,410 shares upon exercise as amended.
The proposal requests shareholder approval to amend previously issued Prior Warrants by lowering their exercise price from $2.41 to $0.6055 per share — matching the public offering Unit price — pursuant to an Existing Warrants Amendment Agreement entered in connection with the February 2026 Offering. Management and Armistice negotiated the repricing as part of the Offering consideration and the repricing is conditioned on shareholder approval under Nasdaq Listing Rule 5635(d) because the repriced issuance would fall within the six-month repricing restriction and the expected repriced exercise price is below the Minimum Price at original issuance. The board recommends a FOR vote, arguing the repricing facilitates exercise that could provide capital and aligns economic terms with the Offering; opposition risks include significant dilution (up to 3,020,410 additional shares), downward pressure on market price from increased share supply, and the possibility that if not approved the company will not receive proceeds from warrant exercises given current market price. The company frames this as necessary for the economic mechanics of the Offering and to secure the benefits of the negotiated arrangements, while emphasizing potential negative effects on existing shareholders’ ownership percentages and market value.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | HRT FINANCIAL LP | 4.0% | 266,393 | $95 |
| 2 | Virtu Financial LLC | 0.7% | 47,809 | $17 |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.5% | 33,280 | $12K |
| 4 | CITADEL ADVISORS LLC | 0.4% | 26,083 | $9K |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 0.2% | 12,023 | $4K |
| 6 | CITIGROUP INC | 0.2% | 10,528 | $4K |
| 7 | Tower Research Capital LLC (TRC | 0.1% | 10,000 | $4K |
| 8 | Golden State Wealth Management, LLC | 0.1% | 10,000 | $4K |
| 9 | JANE STREET GROUP, LLC | 0.1% | 8,998 | $3K |
| 10 | UBS Group AG | 0.1% | 6,622 | $2K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.
